Keratinocyte growth factor gene therapy ameliorates ulcerative colitis in rats

被引:0
|
作者
Chun-Jie Liu
机构
关键词
Keratinocyte growth factor; Ulcerative colitis; Gene therapy; Attenuated Salmonella typhimurium;
D O I
暂无
中图分类号
R574.62 [结肠疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM:To investigate the effect of keratinocyte growth factor(KGF) gene therapy in acetic acid-induced ulcerative colitis in rat model.METHODS:The colitis of Sprague-Dawley rats was induced by intrarectal infusion of 1 mL 5%(v/v) acetic acid.Twenty-four hours after exposed to acetic acid,rats were divided into three experimental groups:control group,attenuated Salmonella typhimurium Ty21a strain(SP) group and SP strain carrying human KGF gene(SPK) group,and they were separately administered orally with 10% NaHCO3,SP or SPK.Animals were sacrificed and colonic tissues were harvested respectively on day 3,5,7 and 10 after administration.Weights of rats,colonic weight/length ratio and stool score were evaluated.Histological changes of colonic tissues were examined by hematoxylin and eosin(HE) staining method.The expression of KGF,KGF receptor(KGFR) and TNF-α were measured either by enzyme-linked immunosorbent assay or Western blotting.Immunohistochemistry was used to detect the cellular localization of KGFR and Ki67.In addition,superoxide dismutase(SOD) activity and malondialdehyde(MDA) contents in the homogenate were measured.RESULTS:Body weight and colonic weight/length ratio were declined in SPK group compared with SP and control groups(body weight:272.78 ± 17.92 g vs 243.72 ± 14.02 g and 240.68 ± 12.63 g,P < 0.01;colonic weight/length ratio:115.76 ± 7.47 vs 150.32 ± 5.99 and 153.67 ± 5.50 mg/cm,P < 0.01).Moreover,pathological changes of damaged colon were improved in SPK group as well.After administration of SPK strain,KGF expression increased markedly from the 3rd d,and remained at a high level till the 10th d.Furthermore,KGFR expression and Ki67 expression elevated,whereas TNF-α expression was inhibited in SPK group.In the group administered with SPK,SOD activity increased significantly(d 5:26.18 ± 5.84 vs 18.12 ± 3.30 and 18.79 ± 4.74 U/mg,P < 0.01;d 7:35.48 ± 3.35 vs 22.57 ± 3.44 and 21.69 ± 3.94 U/mg,P < 0.01;d 10:46.10 ± 6.23 vs 25.35 ± 4.76 and 27.82 ± 6.42 U/mg,P < 0.01) and MDA contents decreased accordingly(d 7:7.40 ± 0.88 vs 9.81 ± 1.21 and 10.45 ± 1.40 nmol/mg,P < 0.01;d 10:4.36 ± 0.62 vs 8.41 ± 0.92 and 8.71 ± 1.27 nmol/mg,P < 0.01),compared with SP and control groups.CONCLUSION:KGF gene therapy mediated by attenuated Salmonella ameliorates ulcerative colitis induced by acetic acids,and it may be a safe and effective treatment for ulcerative colitis.
引用
收藏
页码:2632 / 2640
页数:9
相关论文
共 50 条
  • [31] Intestinal mucosal secretion of basic fibroblast growth factor in patients with ulcerative colitis
    Thörn, M
    Raab, Y
    Larsson, A
    Gerdin, B
    Hällgren, R
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (04) : 408 - 412
  • [32] Effect of ulcerative colitis activity on plasma concentration of transforming growth factor β1
    Wiercinska-Drapalo, A
    Flisiak, R
    Prokopowicz, D
    CYTOKINE, 2001, 14 (06) : 343 - 346
  • [33] Transforming growth factor-β1 and its receptors in patients with ulcerative colitis
    Stadnicki, Antoni
    Machnik, Grzegorz
    Klimacka-Nawrot, Ewa
    Wolanska-Karut, Anna
    Labuzek, Krzysztof
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (06) : 761 - 766
  • [34] Ulcerative colitis activity index:: a useful prognostic factor for predicting ulcerative colitis outcome
    Gürel, S
    Kiyici, M
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2005, 33 (01) : 103 - 110
  • [35] Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization
    Wu, Mei-Mei
    Wang, Qiu-Mei
    Huang, Bao-Yuan
    Mai, Chu-Tian
    Wang, Chun-Li
    Wang, Tian-Tian
    Zhang, Xiao-Jun
    PHARMACOLOGICAL RESEARCH, 2021, 172
  • [36] Infliximab as rescue therapy in ulcerative colitis
    Stephen B. Hanauer
    Current Gastroenterology Reports, 2005, 7 (6) : 465 - 466
  • [37] The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis
    LeBlanc, Jean-Frederic
    Segal, Jonathan P.
    de Campos Braz, Lucia Maria
    Hart, Ailsa L.
    NUTRIENTS, 2021, 13 (06)
  • [38] Indication for surgical therapy in ulcerative colitis
    Rentsch, Markus
    McSharry, Cathleen
    Kuehn, Florian
    Sint, Alena
    Ganschow, Petra
    Werner, Jens
    Schiergens, Tobias
    COLOPROCTOLOGY, 2020, 42 (04) : 339 - 344
  • [39] Current therapy of ulcerative colitis in children
    Bremner, AR
    Griffiths, DM
    Beattie, RM
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (01) : 37 - 53
  • [40] Therapy of ulcerative colitis: state of the art
    Brain, Oliver
    Travis, Simon P. L.
    CURRENT OPINION IN GASTROENTEROLOGY, 2008, 24 (04) : 469 - 474